Drugs / Hipnos
last change Mar 2022 re-read 3 minutes ago

Hipnos

Developed for
insomnia
Investigated by
EMS

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03814135 Jan 2021 → Feb 2022 insomnia EMS Withdrawn No outcome recorded Stop: Business

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Hipnos ClinicalTrials.gov intervention name — accepted as the source's own label NCT03814135 ↗
Route Oral “1 tablet, oral, once a day.” NCT03814135 ↗